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Abstract
Background: Evidence of effectiveness of mobile health (mHealth) apps as well as their usability as non-drug interventions in
primary care are emerging around the globe.
Objective: This study aimed to explore the feasibility of mHealth app prescription by general practitioners (GPs) and to evaluate
the effectiveness of an implementation intervention to increase app prescription.
Methods: A single-group, before-and-after study was conducted in Australian general practice. GPs were given prescription
pads for 6 mHealth apps and reported the number of prescriptions dispensed for 4 months. After the reporting of month 2, a
2-minute video of one of the apps was randomly selected and sent to each GP. Data were collected through a prestudy questionnaire,
monthly electronic reporting, and end-of-study interviews. The primary outcome was the number of app prescriptions (total,
monthly, per GP, and per GP per fortnight). Secondary outcomes included confidence in prescribing apps (0-5 scale), the impact
of the intervention video on subsequent prescription numbers, and acceptability of the interventions.
Results: Of 40 GPs recruited, 39 commenced, and 36 completed the study. In total, 1324 app prescriptions were dispensed over
4 months. The median number of apps prescribed per GP was 30 (range 6-111 apps). The median number of apps prescribed per
GP per fortnight increased from the pre-study level of 1.7 to 4.1. Confidence about prescribing apps doubled from a mean of 2
(not so confident) to 4 (very confident). App videos did not affect subsequent prescription rates substantially. Post-study interviews
revealed that the intervention was highly acceptable.
Conclusions: mHealth app prescription in general practice is feasible, and our implementation intervention was effective in
increasing app prescription. GPs need more tailored education and training on the value of mHealth apps and knowledge of
prescribable apps to be able to successfully change their prescribing habits to include apps. The future of sustainable and scalable
app prescription requires a trustworthy electronic app repository of prescribable mHealth apps for GPs.
(JMIR Mhealth Uhealth 2020;8(6):e16497) doi: 10.2196/16497
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Introduction
More than 350,000 apps exist in the Medical and Health and
Fitness categories in major app stores [1], with downloads and
revenues in the billions [2]. Their popularity and potential to
influence health-related behaviors make their integration to
medical practice imminent [3]. Pragmatic studies of app
prescription in primary care have been emerging around the
world with varied interventions and results [4-6]. To assist the
integration of apps into clinical practice, mobile health
(mHealth) app repositories have been created, including the
National Health Service App library in the United Kingdom
[7], Health Navigator in New Zealand [8], and other private
entities such as AppScript [9] and the Organization for the
Review of Care and Health Applications [10].
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Given the potential of mHealth apps to help improve the
self-management of chronic conditions, we explored their value
in general practice. Previously, in an overview of systematic
reviews, we explored the possibility of simple integration of
mHealth apps into the general practice setting and proposed a
concept of “prescribable” mHealth apps. These were defined
as proven effective (that is, shown to help achieve measurable
clinical improvements in patients’ conditions), in addition to
being standalone and currently available in the app stores [11].
We also explored the potential barriers to app integration in
Australian general practice [12]. Patients expressed their
preference for doctor-recommended apps; however, doctors
were overwhelmed by the sheer number of available apps and
faced 2 major barriers: not knowing of many prescribable apps
and the lack of trustworthy source to access such apps. To
address these barriers, we developed a brief implementation
intervention. Objectives of this study were to explore the
feasibility of app prescription by general practitioners (GPs)
and to evaluate the effectiveness of an implementation
intervention to increase uptake of app prescription.
Methods
Study Design and Setting
We employed a single-group, before-and-after design. Our study
was conducted in the Australian general practice setting. Ethics
approval was obtained from the Bond University Human
Research Ethics Committee (#OB00017).
Participants and Recruitment
GPs currently working in Australia at least 2 days a week were
eligible to participate in our study. Information about the study
was distributed at 2 annual national GP conferences (GPDU2018
and GP18) and posted to a closed Facebook group called GPs
DownUnder. Recruitment occurred from June 2018 through
November 2018, and data collection occurred from September
2018 until May 2019. Upon completion of the study, GPs were
thanked with Aus $50 gift cards.
Intervention
There were two parts to the intervention. First, prescription pads
for 6 apps were developed (Figure 1). These apps were chosen
because they address conditions relevant in general practice,
have either direct trial evidence (This Way Up: Managing
Depression, St. Vincent’s Hospital Sydney Ltd [13]; Tät – Pelvic
floor exercises, Umeå University, Sweden [14]; Lose-It!, FitNow
Inc [15,16]; CBT-i Coach, US Department of Veteran’s Affairs
[17]) or indirect evidence from trials of similar apps (Smiling
Mind, Smiling Mind Pty Ltd [18-20] and Quit Now: My
QuitBuddy, Australian National Preventative Health Agency
[21]). The apps also had to have stable content, were created or
backed by trustworthy not-for-profit organizations, and were
available for both Apple and Android phones. Five of the apps
were freely available, and one (This Way Up: Managing
Depression) had a one-time purchase price of Aus $59.99. The
cost of apps was not an exclusion criterion as it will help assess
if cost is a barrier to app prescription.
The app prescription pads had individually numbered pages
with a tear-off design. Each app prescription page included the
app’s full name and logo, download instructions, space for the
patient’s name, the reason for prescription, and a disclaimer.
Prescription pads were assembled onto an A4 display stand and
mailed to participating GPs. A letter outlining the study
timelines and procedures along with a short introduction to each
app was included in the shipment.
The second part of the intervention was aimed at enhancing
uptake. Short videos (2 minutes) demonstrating the content,
functions, and features of the apps in detail were created for
each app. A YouTube link to the video randomly selected for
each participant was emailed following their second month’s
reporting.
Our study aimed to change the prescribing behavior of GPs.
Evidence suggests that behavioral interventions are more
effective and sustainable when guided by behavior change
techniques. Our prior research helped to identify the target
behaviors [12]. We based our intervention on the Capability,
Opportunity, Motivation, and Behavior model [22]. Capability
to prescribe apps was addressed through the list of
evidence-based apps and the introductory videos demonstrating
the content, features, and function of the apps; opportunity was
enabled through the purposefully designed stand with the
prescription pads; and motivation was harnessed through the
GPs’ expressed interest in the study that demonstrates their
belief that app prescription would be a good thing to do [23].
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Figure 1. The 6 app prescription pads, showing the front (A), with prescription details and script number in the bottom right corner, and back (B), with
app download instructions and cost.
Procedures
At the beginning of the study, participants signed consent forms
and answered the prestudy questionnaire via the web-based
SurveyMonkey tool (SurveyMonkey Inc, San Mateo, CA). The
survey collected demographic data, contact details, current app
prescription rate in the preceding 2 weeks (self-reported in
ranges: 0, 1-5, 6-10, >10 times), and level of confidence around
app prescription.
The official commencement dates for the study were recorded
as the date that each participant reported they started using the
pads. Every 4 weeks following commencement, participants
were asked to send a photo of the prescription pads
electronically to the research team to provide details of the
number of prescriptions for each app within that month. If
participants took leave from work, the reporting dates were
adjusted to allow for a full 4-week reporting period.
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Qualitative semistructured interviews (10-15 minutes) were
conducted and audio recorded at the end of the study, either
face-to-face or by telephone, to gather feedback on the
intervention. GPs were asked about their knowledge of other
apps and relevant resources outside the study, including the
Handbook of Non-Drug Interventions (HANDI) project by the
Royal Australian College of General Practitioners, which
includes a number of mHealth apps. Interviews were transcribed
verbatim, coded by the lead researcher (OB), and thematically
analyzed to determine the feasibility of the interventions,
barriers, and solutions to the scalability of the intervention to
Australian GPs. The thematic analysis was done in consultation
with a second author (TH).
Sample Size
Prior data [12] indicated that the difference in the response
before and after is normally distributed with a standard deviation
of 10 and a baseline mean of 2 apps prescribed per month per
GP. We calculated that we needed 24 participants to have 80%
power (with α=.05) to detect an increase of app prescription by
at least 6 per month. Taking attrition into account, we planned
to recruit 30 GPs for the study.
Outcomes
Data on app usage were collected for the 2-week period prior
to study commencement and then every month for 4 months.
The primary outcome of the study was the number of app
prescriptions dispensed in total, as an average per month, per
GP, and per GP per fortnight. We calculated the median number
of apps recommended by a GP per fortnight using the following
formula:
m=l + (w(n/2-c))/f
where l is the lower limit of the bin (range) containing the
median, w is the width of the bin, n is the total population, c is
the cumulative count (frequency) up to l, and f is the count in
the median bin.
Prestudy raw numbers are provided in Table 1 (m=1.7 [1 +
(5(39/2-17))/19]). Poststudy numbers are given in the Results
section (m=4.1 [1 + (5(39/2-0))/31]).
Secondary outcomes were confidence around prescribing apps
(measured on a 5-point Likert scale; prestudy and poststudy);
the number of intervention video views and their impact on the
subsequent prescription numbers; and attrition rate. In addition,
the acceptability of the interventions to GPs and their feedback
on the interventions were explored in semistructured interviews.
Descriptive statistics were used to report the frequency of app
use at each time point and confidence in app prescription.
Qualitative data were analyzed thematically.
To conduct the overall analysis of the effect of video exposure
on prescription rates, the 6 separate outcomes (1 for each app)
were considered as one overall global outcome (individual
monthly counts were not aggregated). Initially, a Poisson model
was fitted with the (categorical) explanatory variables specified:
the month (1 to 4), exposure to the video (yes/no), video (1 to
6), and interaction between exposure and video. To account for
the 24 repeated measures collected for each GP (4 timepoints
by 6 apps), a random intercept was fitted. Overdispersion was
assessed using generalized chi-square divided by degrees of
freedom. Due to evidence of overdispersion for the Poisson
model (generalized chi-square/degrees of freedom=2.13), a
negative binomial model was fitted and showed no evidence of
over-dispersion (generalized chi-square/degrees of
freedom=0.98).
Results
Overview
A total of 40 currently practicing Australian GPs were recruited
for this study. One GP dropped out before the beginning of the
study, and 3 GPs dropped out after the second and third data
collection due to relocation and change of jobs. The full 4-month
study was completed by 36 GPs, and we analyzed the data as
intention-to-treat (ITT). The median age of the participants was
40 years, the median length of time in practice was 8.5 years,
and participants worked a median of 4 days a week (Table 1).
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Table 1. Participant demographics and prestudy characteristics, n=39.
n (%)Characteristics
Age (years)
11 (28)≤35
20 (51)36-45
5 (13)46-55
3 (8)≥56
Years in practice
23 (59)≤10
12 (31)11-20
4 (10)≥21
28 (72)Female gender
Geographical distribution
21 (54)Queensland
9 (23)New South Wales
4 (10)Victoria
2 (5)South Australia
2 (5)Western Australia
1 (3)Tasmania
Days worked in a week
8 (21)2
9 (23)3
13 (33)4
9 (23)≥5
Number of apps prescribed in the 2 weeks prior to the study
17 (44)0
19 (49)1-5
3 (8)6-10
Confidence level with app prescribing
7 (18)Not at all (1)
12 (31)Not so (2)
19 (49)Somewhat (3)
1 (3)Very (4)
0Extremely (5)
Prescriptions
In total, 1324 app prescriptions were dispensed over 4 months,
with a mean of 331 prescriptions a month. Figure 2 illustrates
the number of individual app prescriptions within the monthly
totals. The number of apps prescribed per GP per fortnight
increased from an imputed prestudy median of 1.7 to 4.1.
Overall, the Smiling mind app was the most frequently
prescribed (533/1324, 40%), followed by CBT-i Coach
(242/1324, 18%), Managing Depression (167/1324, 13%),
Lose-It! (155/1324, 12%), Quit Now: My QuitBuddy (134/1324,
10%), and Tät Pelvic floor exercises (93/1324, 7%).
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Figure 2. Number of individual app prescriptions shown in the monthly totals.
Figure 3 illustrates the distribution of the total app prescription
per GP. According to the ITT analysis, a median of 30 apps
(range 6-111 apps) was prescribed per GP over the 4 months.
Every GP prescribed at least one app per fortnight, 31 (31/39,
80%) GPs prescribed 1-5 apps, 7 (7/39, 18%) prescribed 6-10
apps, and 1 GP prescribed more than 11 apps. The GPs’
confidence around prescribing apps doubled from a mean of 2
(not so confident) before the study to 4 (very confident) at the
end of the study: 0/39 not confident at all; 1/39 (3%) not so
confident; 12/39 (31%) somewhat confident; 25/39 (64%) very
confident; 1/39 (3%) extremely confident.
At the end of the study, the My QuitBuddy app video was
viewed 8 times; the Smiling mind, Managing Depression, and
Lose-It! app introduction videos were viewed 9 times each; the
Tat-Pelvic floor exercise video was viewed 19 times; and the
CBT-i Coach video was viewed 21 times. We were not able to
track whether every GP watched the video sent to them. The
effects of exposure to app videos are shown in Figure 4. Only
two of the app videos had a significant effect on the subsequent
app prescription numbers following the exposure to the video:
Smiling Mind app prescription increased from 3-4 times per
month to 6 times per month, and Lose-It! app prescription
increased by one time. The full analysis is provided in
Multimedia Appendix 1. A global test for the interaction
between exposure and video showed strong evidence of
heterogeneity (P<.001) indicating the treatment effects were
different across the 6 apps. Therefore, we did not report an
overall effect of the videos.
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Figure 3. Distribution of total app prescription per general practitioner (GP). The red dot indicates the median (30 apps), the white dots indicate the
participants who dropped out, and the dashed circle represents the participant who never commenced.
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Figure 4. Mean number of app prescriptions per general practitioner (GP) before and after exposure to the intervention video in each month.
Qualitative Interviews
As per the ITT analysis, 39 GPs were interviewed at the
conclusion of their participation in the study. Participants
expressed their overall experience of prescribing apps as
overwhelmingly positive. They liked the size of the prescription
pad, the information included on it, ease of use, and integration
into the workflow, with the most useful feature identified as the
visual cue aspect of the stand. They also liked the short length
of the videos, yet felt they contained sufficient details about the
apps. Most GPs reported not downloading and interacting with
the apps themselves. Although most reported having watched
the allocated video, many did not recall the contents during the
poststudy interviews.
Two of the 6 study apps were well known to the GPs: 28/39
GPs were already familiar with Smiling Mind, and 12/39 GPs
were already familiar with Managing Depression. They had
been recommending these apps to their patients even before the
study and appreciated having a formal prescription to give out
during the study. Among the other apps that GPs recommended,
mindfulness and meditation apps (Calm, Headspace) were
common. Mental health–related apps were the most frequently
prescribed, and all GPs reported that the overall number of apps
they prescribed is a reflection of the demographics of their
patients and the prevalence of conditions encountered.
GPs reported that they might have prescribed the weight loss
and pelvic floor exercise apps more frequently. Instead, they
habitually referred patients to dietitians and physiotherapists or
to programs and tools already compiled as the first line of
intervention. None of the GPs, except for one, had watched,
read, or received any other app-related content apart from the
study intervention. Knowledge of HANDI was low, especially
that apps were included in some HANDI entries. However, upon
learning this, they all agreed that HANDI would be a reliable
evidence-based app repository for GPs in Australia. The main
barriers and facilitators to app prescription in general practice
are shown in Table 2 along with illustrative quotes.
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Table 2. Key themes and illustrative quotes around barriers and facilitators of mobile health app prescription in general practice.
Illustrative quotesTheme type, theme
Barriers
“I think from a doctor, it's purely just knowledge of health apps.”Poor knowledge and famil-
iarity of prescribable apps
“From the GPa point of view, thinking about it, knowing which ones are good and which ones aren't.”
“challenging because I wasn't necessarily familiar myself with the details of the app in terms of using them myself
or actually being able to really coach patients with using them. I guess that takes time to sit down and actually go
through the apps.”
“Getting into the habit of having those things available was part of the process, trying to trigger the idea that I can
do this was part of it.”
Prescribing habit
“I think trying to, in a busy consultation, trying to remember that as an option that we could recommend to people,
because often you're so busy going, here, have this, do this, have this medication and then you often - adding some
sort of self-help app into this is just part of getting more used to thinking about it as being an option.”
“The depression one was quite an expensive app, that was quite prohibitive to a lot of people.”Cost of apps
“I guess I think cost definitely is a barrier for some patients, especially those that are in financial difficulty because
they even ask for a referral to a bulk-billing psychologist.”
“I think they're probably for me the two big factors, is (one, the doctor's knowledge of them and) two, the patient
perception of how important it is or the value of these health apps in terms of part of their management plan.”
Patients’ capability and atti-
tude towards mHealthb apps
“A lot of my main issue was the demographic of my patients. I didn't realize how much I would struggle to incor-
porate it because I actually have a huge percentage of elderly patients who don't even have smartphones and some
of them that do, don't know how to use the apps properly.”
“time constraints, a lot of the time we're running behind and the app prescription is a slightly luxury, but when we
have time and we're able to be thorough, of course, we can do it, but we don't always have that luxury of time”
Consultation time
“Time is just such a big issue because we're so time-pressured.”
Facilitators
“it's one message consistent and persistent. So if you've got a list that you're confident in, then why are you confident
in it, what's the message behind and then you get it out as many ways as you can because none of us is looking at
Tailored education, face-to-
face training, and informa-
everything all the time. So if there's some way to get it out to the colleges, is there some way to get it out of thetion dissemination to in-
journals, is there somewhere to put it online somewhere that's an authoritative source, is there some way to get it
out through the universities? Word of mouth is always good, influencers, social media…
crease knowledge of pre-
scribable apps
“Coming and meeting us and going through face to face, maybe demonstrating some, a bit like the drug reps do”
“I mean getting doctors early, so getting them through their training programs, getting them as GP registrars and
making it part of there, I think that's where you're going to really get significant change.”
“GP's own familiarity with the app, that if you're familiar with it, it's going to be much easier to prescribe than
something that you have just head about or read about.“
Meaningful familiarity with
apps
“I think certainly the more hands-on you can get, I've done a couple or participated in a couple of webinars from
the e-mental health stuff probably a year or two ago and that helped with my awareness of things, but my confidence
I don’t think improved too much. I think you've got to do them. You've either got to… Use it yourself or see it
being used or at least be familiar with what it looks like.”
“I think having somebody external to narrow down the pool of apps and say this is a decent product, then you don’t
mind recommending them in that way.”
Trustworthy source of vetted
prescribable apps
“if it's coming from a reliable source like the university and say these are the apps we think are good quality apps
to recommend, then I feel comfortable because there is so much information on the internet and app world, we
don't know which is good quality and which is fake.”
“I think it would be brilliant to have an app that I could use for chronic disease management that actually was inte-
grated, that the patients could potentially put data into that will then be integrated with my software, that would be
fantastic.”
Integration with existing
software and workflow
“Certainly, would help to have them integrated into our - the fact that we've prescribed them, into our software,
medical software, so that we can just click a button to say recommended whichever app.”
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Illustrative quotesTheme type, theme
“having those pads in front of me made me think about it, the reminders and having a resource to go to.”Visual reminder or cue for
prescribable apps
“I think having something like you did that makes it easy to give them out, that makes it easier and not having too
many, just having a few that is quite good.”
“most of the current population, the phone is the one thing that they carry around that they have with them all the
time. Instead of - especially them being able to use it as an extra tool, they're useful in the way of treating patients.”
Patients’ capability and atti-
tude towards mHealth apps
“sometimes the apps were very useful for patients who I was aware weren't able to afford other options. So for
example, the pelvic floor exercises app would sometimes occur to me when I was talking to patients about the
difficulties of accessing physiotherapy due to the cost and it would then prompt me to think, oh yes, actually I have
an app that you could try at home without cost.”
Proof of benefits of apps as
an alternative and or adjunct
treatment
“maybe some data showing that they are received well by patients, I guess. apps showing patient receptiveness
and patient engagement”
aGP: general practitioner.
bmHealth: mobile health.
Discussion
This study demonstrated that it may be possible to increase the
uptake of mHealth app prescription by providing an
implementation intervention in the Australian general practice
setting. The results demonstrated a total of 1324 app
prescriptions by 39 GPs over 4 months and positive feedback
from GPs about the intervention. The fortnightly number of
apps prescribed per GP more than doubled compared to the
prestudy level. However, identified barriers to app prescription
uptake were poor knowledge of prescribable apps and
insufficient familiarity with the apps to foster confident
prescribing habits. Participants identified a need for a reliable
prescribable app repository, preferably integrated with their
electronic medical systems, and consistent and persistent
messaging to increase the knowledge and familiarity of such
apps.
The variation in the total individual tally of apps prescribed by
participants may reflect differences in their personal digital
propensity and flexibility in altering prescribing behavior. The
reduction in the monthly app prescriptions after the first month
could be related to the timing of the second and third reporting
for about half of the participants. These occurred during the
Christmas, New Year, and summer holidays in Australia, during
which acute conditions dominate GP visits more than chronic
conditions, which were the focus of the apps in the intervention.
The app explanation videos had varying effects on app
prescription numbers. The results from the qualitative interviews
showed that app prescription numbers are primarily dependent
on the patient cohort and the prevalence of the conditions for
which the intervention apps were intended. Thus, the short
explanatory videos were informative but unlikely to be sufficient
to influence complex behaviors such as prescribing. Perhaps,
it would be more beneficial if video introduction and instructions
for mHealth apps were developed for patients and given as part
of the app prescription.
This is the first study to test the feasibility of an intervention to
increase app prescription in Australian general practice. The
overall attrition rate was low, and we analyzed the data as ITT,
including those who dropped out of the study. Limitations
include lack of access to electronic medical record data of the
GP clinics to correlate the prevalence of conditions with the
frequency of app prescription within the patient cohort. We
aimed to recruit a sample of GPs representative of the national
GP cohort; however, our participants’ median age of 40 years
was younger than the national average of 50-55 years. Other
limitations include a single-group pre-post study design, possible
volunteer bias of the participants, and short time frame (4
months). Ideally, a randomized controlled trial should be
conducted to establish the long-term effectiveness of the
intervention with a large and representative sample for a longer
duration. Due to the restrictions of available time and resources,
we were unable to achieve this. Future studies should also opt
for an electronic version of app prescription to improve
sustainability and scalability. Another limitation is the analysis
of qualitative data by a single researcher; however, the
qualitative data result was a small part of our secondary outcome
to primarily answer if the intervention was acceptable and
feasible for practicing GPs.
There are few comparable studies of app recommendation in a
primary care setting. A trial for an app prescription platform,
AppSalut, in Spain involved 32 doctors who made 79 app
recommendations in 5 months. Of the three apps they used, a
medication adherence app was the most prescribed [4]. It sends
the prescribed app to patients as text messages and can monitor
and receive data on patients’ use and adherence to the system.
In the United States, the Cambridge Health Alliance network
of primary care clinics implemented a mental health app
dissemination program, in which they evaluated mental health
apps, selected 7 apps, and recommended these 7 apps in 12
primary care clinics [5]. Similar to the finding of our study, app
prescriptions for anxiety and stress were the most frequently
prescribed. An Australian study tested the feasibility of
integrating mHealth apps into dietetic practice by asking 5
dietitians to use one chosen app for 12 weeks [6].
All of these studies provided training to the participating health
care professionals to educate them about the study apps as well
as the electronic systems they needed to use. The qualitative
feedback from our participants also included the need for such
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training. However, because GPs often report being overworked,
time-poor, and inundated with different information and offers,
it would be challenging to organize out-of-hours training
involving many GPs or train dedicated personnel to visit GP
clinics during lunch hours, which was suggested by the GPs as
a solution. The scalability of such an intervention would pose
funding and logistical challenges.
One way to promote the sustainability and scalability of mHealth
app integration into clinical practice is to provide an electronic
repository of vetted and curated apps for health care
professionals. In Australia, the Victoria Department of Health
[24], Black Dog Institute [25], and HANDI project by the Royal
Australian College of General Practitioners [26] offer small
repositories of mHealth apps, but these organizations function
under different jurisdictions with no national guideline in place.
GPs in our study emphasized the need for a nationally accessible
repository of a select few prescribable apps that are relevant to
general practice that is safe, reliable, and easy to navigate.
We found that mHealth app prescription is feasible in a general
practice setting in Australia by addressing previously identified
practical barriers to mHealth app prescription. Our
implementation intervention was effective in increasing app
prescription. However, the future of app prescription depends
on efforts to increase GPs’ knowledge of prescribable apps as
well as a dedicated trustworthy app repository for GPs.
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